Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

818 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care.
Shah PL, Orton CM, Grinsztejn B, Donaldson GC, Crabtree Ramírez B, Tonkin J, Santos BR, Cardoso SW, Ritchie AI, Conway F, Riberio MPD, Wiseman DJ, Tana A, Vijayakumar B, Caneja C, Leaper C, Mann B, Samson A, Bhavsar PK, Boffito M, Johnson MR, Pozniak A, Pelly M; PIONEER trial group. Shah PL, et al. Among authors: mann b. Lancet Respir Med. 2023 May;11(5):415-424. doi: 10.1016/S2213-2600(22)00412-X. Epub 2022 Dec 14. Lancet Respir Med. 2023. PMID: 36528039 Free PMC article. Clinical Trial.
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
Compagnucci A, Chan MK, Saïdi Y, Cressey TR, Bamford A, Riault Y, Coelho A, Nolan A, Chalermpantmetagul S, Morkunaite G, Amuge P, Musiime V, Violari A, Cotton M, Kekitiinwa AR, Kaudha E, Groenewald M, Liberty AA, Kanjanavanit S, Volokha A, Bologna R, Pavia Ruz N, Prieto Tato L, Paioni P, Marques L, Reliquet V, Niehues T, Welch SB, Ford D, Giaquinto C, Gibb DM, Babiker A, Ramos Amador JT; SMILE-PENTA17-ANRS 152 Trial Group. Compagnucci A, et al. EClinicalMedicine. 2023 Jun 2;60:102025. doi: 10.1016/j.eclinm.2023.102025. eCollection 2023 Jun. EClinicalMedicine. 2023. PMID: 37304494 Free PMC article.
Safety and real-world effectiveness in the transition from Alteplase to Tenecteplase for stroke treatment.
Halabi ML, Stang J, Menon BK, Buck BH, McIntosh CJ, Wilton SB, Valaire S, Mann B, Collins L, Taralson C, Beaulieu L, Shand E, Hartley C, Dalgleish C, Nickonchuk A, Erfle S, Imoukhuede O, M Alzate HA, Lin K, Coutts SB, Jeerakathil T, Shuaib A, Demchuk AM, Hill MD. Halabi ML, et al. Among authors: mann b. Can J Neurol Sci. 2025 Jun 27:1-16. doi: 10.1017/cjn.2025.10121. Online ahead of print. Can J Neurol Sci. 2025. PMID: 40571961 No abstract available.
Rural Field Consultation for Remote Acute Stroke Transport Decisions.
Panzini MA, Halabi ML, Stang J, Holodinsky JK, Bredenkamp A, Erfle S, Mann B, Vogelaar G, Montpetit J, Jeerakathil T, Buck BH, Ganesh A, Demchuk AM, Hill MD; Stroke Provincial Integration Network. Panzini MA, et al. Among authors: mann b. Can J Neurol Sci. 2025 Jun 3:1-7. doi: 10.1017/cjn.2025.10138. Online ahead of print. Can J Neurol Sci. 2025. PMID: 40458035
818 results